Erlotinib vs Pasireotide

## Erlotinib vs Pasireotide: Overview

This comparison examines the pharmacological differences between **Erlotinib** and **Pasireotide**.

## Mechanism of Action

**Erlotinib**: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

## Pharmacokinetics

**Half-life**: Erlotinib — 36 hours; Pasireotide — N/A.

## Chemical Properties

**Molecular Formula**: Erlotinib — C22H23N3O4; Pasireotide — N/A.

**Molecular Weight**: Erlotinib — 393.4380 g/mol; Pasireotide — N/A.

**Type**: Erlotinib — Small molecule; Pasireotide — Protein.